BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice

類似資料

• Structural Determinants of Opioid and NOP Receptor Activity in Derivatives of Buprenorphine
  著者:: Cami-Kobeci, Gerta, 等
  出版事項: (2011)
• Antidepressant‐like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice
  著者:: Almatroudi, Abdulrahman, 等
  出版事項: (2017)
• The First Universal Opioid Ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): Characterization of the In Vitro Profile and In Vivo Behavioral Effects in Mouse Models of Acute Pain and Cocaine-Induced Reward
  著者:: Khroyan, Taline V., 等
  出版事項: (2011)
• Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile
  著者:: Vinod Kumar, 等
  出版事項: (2018-09-01)
• Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Agonists
  著者:: Khroyan, Taline V., 等
  出版事項: (2009)